Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erysipelas].

Mónica Caetano1, Isabel Amorin

  • 1Serviço de Dermatovenereologia, Hospital Geral de Santo António, S.A., Porto.

Acta Medica Portuguesa
|April 14, 2006
PubMed
Summary

Erysipelas, a bacterial skin infection primarily affecting the lower limbs, is diagnosed clinically. Managing risk factors like lymphoedema and obesity is crucial to prevent recurrence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis.

Clinical drug investigation·2023
Same author

[Non-Necrotizing Acute Dermo-Hypodermal Infections: Erysipela and Infectious Cellulitis].

Acta medica portuguesa·2021
Same author

DermSurgery: Z-plasty transposition flap for reconstruction of the medial eyebrow.

European journal of dermatology : EJD·2019
Same author

Nasolabial flap - alternative uses for a classic but versatile technique.

Dermatology online journal·2018
Same author

Cutaneous lesions and finger clubbing uncovering hypocomplementemic urticarial vasculitis and hepatitis C with mixed cryoglobulinemia.

Anais brasileiros de dermatologia·2014
Same author

Congenital multiple clustered dermatofibroma and multiple eruptive dermatofibromas--unusual presentations of a common entity.

Anais brasileiros de dermatologia·2013

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Bacteriology

Context:

  • Erysipelas is an acute, non-necrotizing bacterial infection of the skin and subcutaneous tissue.
  • Group A beta-hemolytic streptococcus is the primary causative agent.
  • Lower limb involvement occurs in over 80% of cases.

Purpose:

  • To describe the clinical presentation, diagnosis, and management of erysipelas.
  • To highlight key risk factors and differential diagnoses.
  • To emphasize the importance of preventing recurrence.

Summary:

  • Diagnosis is primarily clinical, relying on an acute inflammatory plaque accompanied by fever, lymphangitis, adenopathy, and leukocytosis.
  • Risk factors include disrupted skin barrier, lymphoedema, and obesity.
  • Penicillin is the standard treatment, with consideration for newer agents; managing risk factors is vital for preventing recurrence.

Impact:

  • Improved understanding of erysipelas diagnosis and clinical management.
  • Highlights the significance of addressing underlying risk factors to reduce disease recurrence.
  • Informs clinical practice regarding differential diagnosis and appropriate therapeutic strategies.

Related Experiment Videos